Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9351
    Short Description Topotecan injection
    Long Description Injection, topotecan, 0.1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 2018-01-01
    Date Added 2011-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00078067461 J9351 Topotecan injection Hycamtin NOVARTIS PHARMACEUTICALS CORPORATION 0.1 MG 1 1 40 40
    00409030201 J9351 Topotecan injection Topotecan PFIZER INC. 0.1 MG 1 1 40 40
    00703471401 J9351 Topotecan injection Topotecan SICOR PHARMACEUTICALS, INC. 0.1 MG 1 1 40 40
    16729015131 J9351 Topotecan injection Topotecan ACCORD HEALTHCARE INC. 0.1 MG 1 1 40 40
    16729024331 J9351 Topotecan injection Topotecan ACCORD HEALTHCARE INC. 0.1 MG 4 1 40 40
    45963061556 J9351 Topotecan injection Topotecan ACTAVIS PHARMA, INC. 0.1 MG 1 1 40 40
    63323076210 J9351 Topotecan injection Topotecan FRESENIUS KABI 0.1 MG 1 1 40 40
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    Drug Details

    • Topotecan is used to treat small cell lung cancer (a type of cancer that begins in the lungs) that was successfully treated with a different chemotherapy medication but has returned no sooner than 45 days after the last dose of the first chemotherapy medication was taken. Topotecan is in a class of medications called topoisomerase I inhibitors. It works by killing cancer cells.